Sharechat Logo

Fletcher Building shares drop 5.7% as investors seek yield elsewhere

Wednesday 22nd August 2018

Text too small?

Fletcher Building shares dropped 5.7 percent despite news it expects to resume paying dividends in the 2019 financial year as investors look for more immediate yield.

The company reported a net loss of $190 million for the 12 months to June 30, turning around a profit of $94 million in the prior year. Earlier this year, the construction company suspended its interim dividend and didn't declare a final payment. Today Fletcher said it expects "subject to satisfactory trading performance" to be able to resume dividends in the current financial year.

Alexandra Dalzell, an investment adviser at Craigs Investment Partners, said there is little reason to hold the stock given there is no dividend until 2019 "in a market that needs income" as the central bank has indicated rates will stay low for longer and it could even cut the official cash rate against a backdrop of weaker-than-expected growth. 

"Why would you be there?" she said. "Dividend stocks will be the most rewarded longer term." 

Fletcher's operating losses fell within its own guidance and the company contained expected losses from its B+I division, which have weighed on the company during the past year. 

The stock recently traded at $6.51 and is now down 12 percent so far this year. 

(BusinessDesk)

 




  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors